0001156784 false Q1 --12-31 http://fasb.org/us-gaap/2023#RelatedPartyMember http://fasb.org/us-gaap/2023#RelatedPartyMember P5Y P5Y P5Y P5Y P5Y P5Y P5Y P5Y 0001156784 2023-01-01 2023-03-31 0001156784 2023-05-19 0001156784 2023-03-31 0001156784 2022-12-31 0001156784 us-gaap:NonrelatedPartyMember 2023-03-31 0001156784 us-gaap:NonrelatedPartyMember 2022-12-31 0001156784 us-gaap:RelatedPartyMember 2023-03-31 0001156784 us-gaap:RelatedPartyMember 2022-12-31 0001156784 COWI:RedeemablePreferredStockSeriesAMember 2023-03-31 0001156784 COWI:RedeemablePreferredStockSeriesAMember 2022-12-31 0001156784 COWI:RedeemablePreferredStockSeriesBMember 2023-03-31 0001156784 COWI:RedeemablePreferredStockSeriesBMember 2022-12-31 0001156784 COWI:RedeemablePreferredStockSeriesCMember 2023-03-31 0001156784 COWI:RedeemablePreferredStockSeriesCMember 2022-12-31 0001156784 COWI:RedeemablePreferredStockSeriesDMember 2023-03-31 0001156784 COWI:RedeemablePreferredStockSeriesDMember 2022-12-31 0001156784 COWI:RedeemablePreferredStockSeriesEMember 2023-03-31 0001156784 COWI:RedeemablePreferredStockSeriesEMember 2022-12-31 0001156784 COWI:RedeemablePreferredStockSeriesFMember 2023-03-31 0001156784 COWI:RedeemablePreferredStockSeriesFMember 2022-12-31 0001156784 COWI:RedeemablePreferredStockSeriesGMember 2023-03-31 0001156784 COWI:RedeemablePreferredStockSeriesGMember 2022-12-31 0001156784 us-gaap:LicensingAgreementsMember 2023-03-31 0001156784 us-gaap:LicensingAgreementsMember 2022-12-31 0001156784 2022-01-01 2022-03-31 0001156784 us-gaap:PreferredStockMember us-gaap:RedeemablePreferredStockMember 2021-12-31 0001156784 us-gaap:CommonStockMember 2021-12-31 0001156784 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001156784 us-gaap:TreasuryStockCommonMember 2021-12-31 0001156784 us-gaap:RetainedEarningsMember 2021-12-31 0001156784 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0001156784 2021-12-31 0001156784 us-gaap:PreferredStockMember COWI:RedeemablePreferredStockSeriesBMember 2021-12-31 0001156784 us-gaap:PreferredStockMember COWI:RedeemablePreferredStockSeriesDMember 2021-12-31 0001156784 us-gaap:PreferredStockMember COWI:RedeemablePreferredStockSeriesEMember 2021-12-31 0001156784 us-gaap:PreferredStockMember COWI:RedeemablePreferredStockSeriesFMember 2021-12-31 0001156784 us-gaap:PreferredStockMember COWI:RedeemablePreferredStockSeriesGMember 2021-12-31 0001156784 us-gaap:PreferredStockMember us-gaap:RedeemablePreferredStockMember 2022-12-31 0001156784 us-gaap:CommonStockMember 2022-12-31 0001156784 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001156784 us-gaap:TreasuryStockCommonMember 2022-12-31 0001156784 us-gaap:RetainedEarningsMember 2022-12-31 0001156784 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0001156784 us-gaap:PreferredStockMember COWI:RedeemablePreferredStockSeriesBMember 2022-12-31 0001156784 us-gaap:PreferredStockMember COWI:RedeemablePreferredStockSeriesDMember 2022-12-31 0001156784 us-gaap:PreferredStockMember COWI:RedeemablePreferredStockSeriesEMember 2022-12-31 0001156784 us-gaap:PreferredStockMember COWI:RedeemablePreferredStockSeriesFMember 2022-12-31 0001156784 us-gaap:PreferredStockMember COWI:RedeemablePreferredStockSeriesGMember 2022-12-31 0001156784 us-gaap:PreferredStockMember us-gaap:RedeemablePreferredStockMember 2022-01-01 2022-03-31 0001156784 us-gaap:CommonStockMember 2022-01-01 2022-03-31 0001156784 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0001156784 us-gaap:TreasuryStockCommonMember 2022-01-01 2022-03-31 0001156784 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0001156784 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-03-31 0001156784 us-gaap:PreferredStockMember COWI:RedeemablePreferredStockSeriesBMember 2022-01-01 2022-03-31 0001156784 us-gaap:PreferredStockMember COWI:RedeemablePreferredStockSeriesDMember 2022-01-01 2022-03-31 0001156784 us-gaap:PreferredStockMember COWI:RedeemablePreferredStockSeriesEMember 2022-01-01 2022-03-31 0001156784 us-gaap:PreferredStockMember COWI:RedeemablePreferredStockSeriesFMember 2022-01-01 2022-03-31 0001156784 us-gaap:PreferredStockMember COWI:RedeemablePreferredStockSeriesGMember 2022-01-01 2022-03-31 0001156784 us-gaap:PreferredStockMember us-gaap:RedeemablePreferredStockMember 2023-01-01 2023-03-31 0001156784 us-gaap:CommonStockMember 2023-01-01 2023-03-31 0001156784 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0001156784 us-gaap:TreasuryStockCommonMember 2023-01-01 2023-03-31 0001156784 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0001156784 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-03-31 0001156784 us-gaap:PreferredStockMember us-gaap:RedeemablePreferredStockMember 2022-03-31 0001156784 us-gaap:CommonStockMember 2022-03-31 0001156784 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001156784 us-gaap:TreasuryStockCommonMember 2022-03-31 0001156784 us-gaap:RetainedEarningsMember 2022-03-31 0001156784 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-03-31 0001156784 2022-03-31 0001156784 us-gaap:PreferredStockMember COWI:RedeemablePreferredStockSeriesBMember 2022-03-31 0001156784 us-gaap:PreferredStockMember COWI:RedeemablePreferredStockSeriesDMember 2022-03-31 0001156784 us-gaap:PreferredStockMember COWI:RedeemablePreferredStockSeriesEMember 2022-03-31 0001156784 us-gaap:PreferredStockMember COWI:RedeemablePreferredStockSeriesFMember 2022-03-31 0001156784 us-gaap:PreferredStockMember COWI:RedeemablePreferredStockSeriesGMember 2022-03-31 0001156784 us-gaap:PreferredStockMember us-gaap:RedeemablePreferredStockMember 2023-03-31 0001156784 us-gaap:CommonStockMember 2023-03-31 0001156784 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001156784 us-gaap:TreasuryStockCommonMember 2023-03-31 0001156784 us-gaap:RetainedEarningsMember 2023-03-31 0001156784 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-03-31 0001156784 us-gaap:PreferredStockMember COWI:RedeemablePreferredStockSeriesBMember 2023-03-31 0001156784 us-gaap:PreferredStockMember COWI:RedeemablePreferredStockSeriesDMember 2023-03-31 0001156784 us-gaap:PreferredStockMember COWI:RedeemablePreferredStockSeriesEMember 2023-03-31 0001156784 us-gaap:PreferredStockMember COWI:RedeemablePreferredStockSeriesFMember 2023-03-31 0001156784 us-gaap:PreferredStockMember COWI:RedeemablePreferredStockSeriesGMember 2023-03-31 0001156784 COWI:CarbonMetaGreenBuildingMaterialsLLCMember 2023-03-31 0001156784 COWI:AriconLLCMember 2023-03-31 0001156784 us-gaap:LicenseAgreementTermsMember 2021-06-01 2021-06-02 0001156784 2021-06-02 0001156784 us-gaap:LicenseAgreementTermsMember us-gaap:LicenseMember 2021-06-01 2021-06-02 0001156784 us-gaap:LicenseAgreementTermsMember us-gaap:PatentsMember srt:AmericasMember 2021-06-01 2021-06-02 0001156784 us-gaap:LicenseAgreementTermsMember us-gaap:PatentsMember us-gaap:EuropeanUnionMember 2021-06-01 2021-06-02 0001156784 COWI:LicenseThreeMember 2021-06-01 2021-06-02 0001156784 COWI:LicenseFourMember 2021-06-01 2021-06-02 0001156784 COWI:LicenseOfAgreementMember 2021-12-01 2021-12-02 0001156784 COWI:LicenseOfAgreementMember 2022-02-01 2022-02-17 0001156784 COWI:LicenseOneMember COWI:LicenseeMember 2022-02-01 2022-02-17 0001156784 2022-02-01 2022-02-17 0001156784 2022-02-17 0001156784 COWI:LicenseOneMember 2022-02-01 2022-02-17 0001156784 COWI:LicenseTwoMember 2022-02-01 2022-02-17 0001156784 COWI:LicenseThreeMember 2022-02-01 2022-02-17 0001156784 COWI:LicenseFourMember 2022-02-01 2022-02-17 0001156784 COWI:ProductionAgreementMember 2022-01-11 2022-01-11 0001156784 2022-06-09 2022-06-10 0001156784 2022-07-01 2022-09-30 0001156784 2022-10-01 2022-12-31 0001156784 COWI:SecondServiceAwardMember 2022-10-01 2022-10-31 0001156784 COWI:SecondServiceAwardMember 2023-01-01 2023-01-31 0001156784 COWI:AssetsAndLiabilitiesMember 2023-03-31 0001156784 COWI:RevenuesAndExpensesMember 2023-03-31 0001156784 COWI:OxfordLicenseMember 2023-03-31 0001156784 COWI:EcomenaLicenseMember 2023-03-31 0001156784 us-gaap:SeriesBPreferredStockMember 2023-01-01 2023-03-31 0001156784 us-gaap:SeriesBPreferredStockMember 2022-01-01 2022-12-31 0001156784 COWI:ComputerEquipmentAndSoftwareMember 2023-03-31 0001156784 COWI:FilamentProductionEquipmentMember 2023-03-31 0001156784 us-gaap:FairValueInputsLevel1Member 2023-03-31 0001156784 us-gaap:FairValueInputsLevel2Member 2023-03-31 0001156784 us-gaap:FairValueInputsLevel3Member 2023-03-31 0001156784 us-gaap:FairValueInputsLevel1Member 2022-12-31 0001156784 us-gaap:FairValueInputsLevel2Member 2022-12-31 0001156784 us-gaap:FairValueInputsLevel3Member 2022-12-31 0001156784 COWI:OxfordUniversityInnovationLimitedMember 2023-03-31 0001156784 COWI:OxfordUniversityInnovationLimitedMember 2022-12-31 0001156784 COWI:EcomenaLimitedMember 2023-03-31 0001156784 COWI:EcomenaLimitedMember 2022-12-31 0001156784 2021-10-28 0001156784 2021-10-27 2021-10-28 0001156784 COWI:CarbonMetaTechnologiesIncMember 2023-03-31 0001156784 COWI:CoroWareTechnologiesIncMember 2023-03-31 0001156784 COWI:CoroWareRoboticsSolutionsIncMember 2023-03-31 0001156784 COWI:CarbonSourceIncMember 2023-03-31 0001156784 COWI:AriconLLCMember 2023-03-31 0001156784 COWI:KnightCapitalArrangementMember 2023-03-31 0001156784 COWI:KnightCapitalArrangementMember 2022-12-31 0001156784 COWI:QuickFixCapitalArrangementMember 2023-03-31 0001156784 COWI:QuickFixCapitalArrangementMember 2022-12-31 0001156784 COWI:PowerUpArrangementMember 2023-03-31 0001156784 COWI:PowerUpArrangementMember 2022-12-31 0001156784 COWI:PowerUpOneArrangementMember 2023-03-31 0001156784 COWI:PowerUpOneArrangementMember 2022-12-31 0001156784 COWI:PowerUpTwoArrangementMember 2023-03-31 0001156784 COWI:PowerUpTwoArrangementMember 2022-12-31 0001156784 COWI:PowerUpThreeArrangementMember 2023-03-31 0001156784 COWI:PowerUpThreeArrangementMember 2022-12-31 0001156784 COWI:WestmountHoldingsInternationalLtdMember 2023-03-31 0001156784 COWI:WestmountHoldingsInternationalLtdMember 2022-12-31 0001156784 COWI:WestmountHoldingsInternationalLtdMember 2023-01-01 2023-03-31 0001156784 COWI:WestmountHoldingsInternationalLtdMember 2022-01-01 2022-12-31 0001156784 COWI:TangiersInvestmentGroupLLCMember 2023-03-31 0001156784 COWI:TangiersInvestmentGroupLLCMember 2022-12-31 0001156784 COWI:TangiersInvestmentGroupLLCMember 2023-01-01 2023-03-31 0001156784 COWI:TangiersInvestmentGroupLLCMember 2022-01-01 2022-12-31 0001156784 COWI:TangiersInvestmentGroupLLCOneMember 2023-03-31 0001156784 COWI:TangiersInvestmentGroupLLCOneMember 2022-12-31 0001156784 COWI:TangiersInvestmentGroupLLCOneMember 2023-01-01 2023-03-31 0001156784 COWI:TangiersInvestmentGroupLLCOneMember 2022-01-01 2022-12-31 0001156784 COWI:TangiersInvestmentGroupLLCTwoMember 2023-03-31 0001156784 COWI:TangiersInvestmentGroupLLCTwoMember 2022-12-31 0001156784 COWI:TangiersInvestmentGroupLLCTwoMember 2023-01-01 2023-03-31 0001156784 COWI:TangiersInvestmentGroupLLCTwoMember 2022-01-01 2022-12-31 0001156784 COWI:TangiersInvestmentGroupLLCThreeMember 2023-03-31 0001156784 COWI:TangiersInvestmentGroupLLCThreeMember 2022-12-31 0001156784 COWI:TangiersInvestmentGroupLLCThreeMember 2023-01-01 2023-03-31 0001156784 COWI:TangiersInvestmentGroupLLCThreeMember 2022-01-01 2022-12-31 0001156784 COWI:TangiersInvestmentGroupLLCFourMember 2023-03-31 0001156784 COWI:TangiersInvestmentGroupLLCFourMember 2022-12-31 0001156784 COWI:TangiersInvestmentGroupLLCFourMember 2023-01-01 2023-03-31 0001156784 COWI:TangiersInvestmentGroupLLCFourMember 2022-01-01 2022-12-31 0001156784 COWI:TangiersInvestmentGroupLLCFiveMember 2023-03-31 0001156784 COWI:TangiersInvestmentGroupLLCSixMember 2022-12-31 0001156784 COWI:TangiersInvestmentGroupLLCFiveMember 2023-01-01 2023-03-31 0001156784 COWI:TangiersInvestmentGroupLLCFiveMember 2022-01-01 2022-12-31 0001156784 COWI:TangiersInvestmentGroupLLCSixMember 2023-03-31 0001156784 COWI:TangiersInvestmentGroupLLCSixMember 2023-01-01 2023-03-31 0001156784 COWI:TangiersInvestmentGroupLLCSixMember 2022-01-01 2022-12-31 0001156784 COWI:TangiersInvestmentGroupLLCSevenMember 2023-03-31 0001156784 COWI:TangiersInvestmentGroupLLCSevenMember 2022-12-31 0001156784 COWI:TangiersInvestmentGroupLLCSevenMember 2023-01-01 2023-03-31 0001156784 COWI:TangiersInvestmentGroupLLCSevenMember 2022-01-01 2022-12-31 0001156784 COWI:LloydTSpencerMember 2023-03-31 0001156784 COWI:LloydTSpencerMember 2022-12-31 0001156784 COWI:LloydTSpencerMember 2023-01-01 2023-03-31 0001156784 COWI:LloydTSpencerMember 2022-01-01 2022-12-31 0001156784 COWI:DakotaMember 2023-03-31 0001156784 COWI:DakotaMember 2022-12-31 0001156784 COWI:DakotaMember 2023-01-01 2023-03-31 0001156784 COWI:DakotaMember 2022-01-01 2022-12-31 0001156784 COWI:ZoomMarketingMember 2023-03-31 0001156784 COWI:ZoomMarketingMember 2022-12-31 0001156784 COWI:ZoomMarketingMember 2023-01-01 2023-03-31 0001156784 COWI:ZoomMarketingMember 2022-01-01 2022-12-31 0001156784 COWI:BurringtonCapitalLLCMember 2023-03-31 0001156784 COWI:BurringtonCapitalLLCMember 2022-12-31 0001156784 COWI:BurringtonCapitalLLCMember 2023-01-01 2023-03-31 0001156784 COWI:BurringtonCapitalLLCMember 2022-01-01 2022-12-31 0001156784 COWI:PatrickFerroMember 2023-03-31 0001156784 COWI:PatrickFerroMember 2022-12-31 0001156784 COWI:PatrickFerroMember 2023-01-01 2023-03-31 0001156784 COWI:PatrickFerroMember 2022-01-01 2022-12-31 0001156784 COWI:BarryLibenMember 2023-03-31 0001156784 COWI:BarryLibenMember 2022-12-31 0001156784 COWI:BarryLibenMember 2023-01-01 2023-03-31 0001156784 COWI:BarryLibenMember 2022-01-01 2022-12-31 0001156784 COWI:JaredRobertMember 2023-03-31 0001156784 COWI:JaredRobertMember 2022-12-31 0001156784 COWI:JaredRobertMember 2023-01-01 2023-03-31 0001156784 COWI:JaredRobertMember 2022-01-01 2022-12-31 0001156784 COWI:RaphaelCariouMember 2023-03-31 0001156784 COWI:RaphaelCariouMember 2022-12-31 0001156784 COWI:RaphaelCariouMember 2023-01-01 2023-03-31 0001156784 COWI:RaphaelCariouMember 2022-01-01 2022-12-31 0001156784 COWI:RaphaelCariouOneMember 2023-03-31 0001156784 COWI:RaphaelCariouOneMember 2022-12-31 0001156784 COWI:RaphaelCariouOneMember 2023-01-01 2023-03-31 0001156784 COWI:RaphaelCariouOneMember 2022-01-01 2022-12-31 0001156784 COWI:RaphaelCariouTwoMember 2023-03-31 0001156784 COWI:RaphaelCariouTwoMember 2022-12-31 0001156784 COWI:RaphaelCariouTwoMember 2023-01-01 2023-03-31 0001156784 COWI:RaphaelCariouTwoMember 2022-01-01 2022-12-31 0001156784 COWI:RedwoodManagementLlcMember 2023-03-31 0001156784 COWI:RedwoodManagementLlcMember 2022-12-31 0001156784 COWI:RedwoodManagementLlcMember 2023-01-01 2023-03-31 0001156784 COWI:RedwoodManagementLlcMember 2022-01-01 2022-12-31 0001156784 COWI:AgsCapitalGroupLlcMember 2023-03-31 0001156784 COWI:AgsCapitalGroupLlcMember 2022-12-31 0001156784 COWI:AgsCapitalGroupLlcMember 2023-01-01 2023-03-31 0001156784 COWI:AgsCapitalGroupLlcMember 2022-01-01 2022-12-31 0001156784 COWI:AgsCapitalGroupLlcOneMember 2023-03-31 0001156784 COWI:AgsCapitalGroupLlcOneMember 2022-12-31 0001156784 COWI:AgsCapitalGroupLlcOneMember 2023-01-01 2023-03-31 0001156784 COWI:AgsCapitalGroupLlcOneMember 2022-01-01 2022-12-31 0001156784 COWI:TimBurgessMember 2023-03-31 0001156784 COWI:TimBurgessMember 2022-12-31 0001156784 COWI:TimBurgessMember 2023-01-01 2023-03-31 0001156784 COWI:TimBurgessMember 2022-01-01 2022-12-31 0001156784 COWI:AzrielNagarMember 2023-03-31 0001156784 COWI:AzrielNagarMember 2022-12-31 0001156784 COWI:AzrielNagarMember 2023-01-01 2023-03-31 0001156784 COWI:AzrielNagarMember 2022-01-01 2022-12-31 0001156784 COWI:KelburghLtdMember 2023-03-31 0001156784 COWI:KelburghLtdMember 2022-12-31 0001156784 COWI:KelburghLtdMember 2023-01-01 2023-03-31 0001156784 COWI:KelburghLtdMember 2022-01-01 2022-12-31 0001156784 COWI:PremierItSolutionsMember 2023-03-31 0001156784 COWI:PremierItSolutionsMember 2022-12-31 0001156784 COWI:PremierItSolutionsMember 2023-01-01 2023-03-31 0001156784 COWI:PremierItSolutionsMember 2022-01-01 2022-12-31 0001156784 COWI:LGCapitalFundingLLCMember 2023-03-31 0001156784 COWI:LGCapitalFundingLLCMember 2022-12-31 0001156784 COWI:LGCapitalFundingLLCMember 2023-01-01 2023-03-31 0001156784 COWI:LGCapitalFundingLLCMember 2022-01-01 2022-12-31 0001156784 COWI:LGCapitalFundingLLCOneMember 2023-03-31 0001156784 COWI:LGCapitalFundingLLCOneMember 2022-12-31 0001156784 COWI:LGCapitalFundingLLCOneMember 2023-01-01 2023-03-31 0001156784 COWI:LGCapitalFundingLLCOneMember 2022-01-01 2022-12-31 0001156784 COWI:LGCapitalFundingLLCTwoMember 2023-03-31 0001156784 COWI:LGCapitalFundingLLCTwoMember 2022-12-31 0001156784 COWI:LGCapitalFundingLLCTwoMember 2023-01-01 2023-03-31 0001156784 COWI:LGCapitalFundingLLCTwoMember 2022-01-01 2022-12-31 0001156784 COWI:BarclayLyonsMember 2023-03-31 0001156784 COWI:BarclayLyonsMember 2022-12-31 0001156784 COWI:BarclayLyonsMember 2023-01-01 2023-03-31 0001156784 COWI:BarclayLyonsMember 2022-01-01 2022-12-31 0001156784 COWI:BlackridgeCapitalLLCMember 2023-03-31 0001156784 COWI:BlackridgeCapitalLLCMember 2022-12-31 0001156784 COWI:BlackridgeCapitalLLCMember 2023-01-01 2023-03-31 0001156784 COWI:BlackridgeCapitalLLCMember 2022-01-01 2022-12-31 0001156784 COWI:BlackridgeCapitalLLCOneMember 2023-03-31 0001156784 COWI:BlackridgeCapitalLLCOneMember 2022-12-31 0001156784 COWI:BlackridgeCapitalLLCOneMember 2023-01-01 2023-03-31 0001156784 COWI:BlackridgeCapitalLLCOneMember 2022-01-01 2022-12-31 0001156784 COWI:JulianHerskowitzMember 2023-03-31 0001156784 COWI:JulianHerskowitzMember 2022-12-31 0001156784 COWI:JulianHerskowitzMember 2023-01-01 2023-03-31 0001156784 COWI:JulianHerskowitzMember 2022-01-01 2022-12-31 0001156784 COWI:PatrickTuohyMember 2023-03-31 0001156784 COWI:PatrickTuohyMember 2022-12-31 0001156784 COWI:PatrickTuohyMember 2023-01-01 2023-03-31 0001156784 COWI:PatrickTuohyMember 2022-01-01 2022-12-31 0001156784 COWI:RichardWynnsMember 2023-03-31 0001156784 COWI:RichardWynnsMember 2022-12-31 0001156784 COWI:RichardWynnsMember 2023-01-01 2023-03-31 0001156784 COWI:RichardWynnsMember 2022-01-01 2022-12-31 0001156784 COWI:RichardWynnsOneMember 2023-03-31 0001156784 COWI:RichardWynnsOneMember 2022-12-31 0001156784 COWI:RichardWynnsOneMember 2023-01-01 2023-03-31 0001156784 COWI:RichardWynnsOneMember 2022-01-01 2022-12-31 0001156784 COWI:MacRabLLCMember 2023-03-31 0001156784 COWI:MacRabLLCMember 2022-12-31 0001156784 COWI:MacRabLLCMember 2023-01-01 2023-03-31 0001156784 COWI:MacRabLLCMember 2022-01-01 2022-12-31 0001156784 COWI:BHPCapitalNYIncMember 2023-03-31 0001156784 COWI:BHPCapitalNYIncMember 2022-12-31 0001156784 COWI:BHPCapitalNYIncMember 2023-01-01 2023-03-31 0001156784 COWI:BHPCapitalNYIncMember 2022-01-01 2022-12-31 0001156784 COWI:QuickCapitalLLCMember 2023-03-31 0001156784 COWI:QuickCapitalLLCMember 2022-12-31 0001156784 COWI:QuickCapitalLLCMember 2023-01-01 2023-03-31 0001156784 COWI:QuickCapitalLLCMember 2022-01-01 2022-12-31 0001156784 COWI:QuickCapitalLLCOneMember 2023-03-31 0001156784 COWI:QuickCapitalLLCOneMember 2022-12-31 0001156784 COWI:QuickCapitalLLCOneMember 2023-01-01 2023-03-31 0001156784 COWI:QuickCapitalLLCOneMember 2022-01-01 2022-12-31 0001156784 COWI:RobertPapiriMember 2023-03-31 0001156784 COWI:RobertPapiriMember 2022-12-31 0001156784 COWI:RobertPapiriMember 2023-01-01 2023-03-31 0001156784 COWI:RobertPapiriMember 2022-01-01 2022-12-31 0001156784 COWI:RobertPapiriOneMember 2023-03-31 0001156784 COWI:RobertPapiriOneMember 2022-12-31 0001156784 COWI:RobertPapiriOneMember 2023-01-01 2023-03-31 0001156784 COWI:RobertPapiriOneMember 2022-01-01 2022-12-31 0001156784 COWI:RobertPapiriTwoMember 2023-03-31 0001156784 COWI:RobertPapiriTwoMember 2022-12-31 0001156784 COWI:RobertPapiriTwoMember 2023-01-01 2023-03-31 0001156784 COWI:RobertPapiriTwoMember 2022-01-01 2022-12-31 0001156784 COWI:RobertPapiriThreeMember 2023-03-31 0001156784 COWI:RobertPapiriThreeMember 2022-12-31 0001156784 COWI:RobertPapiriThreeMember 2023-01-01 2023-03-31 0001156784 COWI:RobertPapiriThreeMember 2022-01-01 2022-12-31 0001156784 COWI:RPGCapitalPartnersIncMember 2023-03-31 0001156784 COWI:RPGCapitalPartnersIncMember 2022-12-31 0001156784 COWI:RPGCapitalPartnersIncMember 2023-01-01 2023-03-31 0001156784 COWI:RPGCapitalPartnersIncMember 2022-01-01 2022-12-31 0001156784 COWI:RPGCapitalPartnersIncOneMember 2023-03-31 0001156784 COWI:RPGCapitalPartnersIncOneMember 2022-12-31 0001156784 COWI:RPGCapitalPartnersIncOneMember 2023-01-01 2023-03-31 0001156784 COWI:RPGCapitalPartnersIncOneMember 2022-01-01 2022-12-31 0001156784 COWI:RPGCapitalPartnersIncTwoMember 2023-03-31 0001156784 COWI:RPGCapitalPartnersIncTwoMember 2022-12-31 0001156784 COWI:RPGCapitalPartnersIncTwoMember 2023-01-01 2023-03-31 0001156784 COWI:RPGCapitalPartnersIncTwoMember 2022-01-01 2022-12-31 0001156784 2022-01-01 2022-12-31 0001156784 COWI:CorowareIncAndSubsidiariesMember 2023-03-31 0001156784 COWI:CorowareIncAndSubsidiariesMember 2022-12-31 0001156784 COWI:GarySumnerMember COWI:CorowareIncAndSubsidiariesMember 2023-03-31 0001156784 COWI:GarySumnerMember COWI:CorowareIncAndSubsidiariesMember 2022-12-31 0001156784 COWI:LtcInternationalCorpMember COWI:CorowareIncAndSubsidiariesMember 2023-03-31 0001156784 COWI:LtcInternationalCorpMember COWI:CorowareIncAndSubsidiariesMember 2022-12-31 0001156784 COWI:RichardWynnsMember COWI:CorowareIncAndSubsidiariesMember 2023-03-31 0001156784 COWI:RichardWynnsMember COWI:CorowareIncAndSubsidiariesMember 2022-12-31 0001156784 COWI:BarclayLyonsMember COWI:CorowareIncAndSubsidiariesMember 2023-03-31 0001156784 COWI:BarclayLyonsMember COWI:CorowareIncAndSubsidiariesMember 2022-12-31 0001156784 COWI:JohnKroonMember COWI:CorowareIncAndSubsidiariesMember 2023-03-31 0001156784 COWI:JohnKroonMember COWI:CorowareIncAndSubsidiariesMember 2022-12-31 0001156784 COWI:WalterJayBellMember COWI:CorowareIncAndSubsidiariesMember 2023-03-31 0001156784 COWI:WalterJayBellMember COWI:CorowareIncAndSubsidiariesMember 2022-12-31 0001156784 COWI:WalterJayBell1Member COWI:CorowareIncAndSubsidiariesMember 2023-03-31 0001156784 COWI:WalterJayBell1Member COWI:CorowareIncAndSubsidiariesMember 2022-12-31 0001156784 COWI:GeorgeFerchMember COWI:CorowareIncAndSubsidiariesMember 2023-03-31 0001156784 COWI:GeorgeFerchMember COWI:CorowareIncAndSubsidiariesMember 2022-12-31 0001156784 COWI:BlackbridgeLlcMember COWI:CorowareIncAndSubsidiariesMember 2023-03-31 0001156784 COWI:BlackbridgeLlcMember COWI:CorowareIncAndSubsidiariesMember 2022-12-31 0001156784 COWI:MichaelSobeckMember COWI:CorowareIncAndSubsidiariesMember 2023-03-31 0001156784 COWI:MichaelSobeckMember COWI:CorowareIncAndSubsidiariesMember 2022-12-31 0001156784 COWI:GarySumnerMember COWI:CorowareIncAndSubsidiariesMember 2017-06-28 2017-06-29 0001156784 COWI:GarySumnerMember COWI:CorowareIncAndSubsidiariesMember 2017-06-29 0001156784 COWI:LtcInternationalCorpMember COWI:CorowareIncAndSubsidiariesMember 2018-07-02 2018-07-03 0001156784 COWI:LtcInternationalCorpMember COWI:CorowareIncAndSubsidiariesMember 2018-07-03 0001156784 COWI:RichardWynnsMember COWI:CorowareIncAndSubsidiariesMember 2010-07-26 2010-07-27 0001156784 COWI:RichardWynnsMember COWI:CorowareIncAndSubsidiariesMember 2010-07-27 0001156784 COWI:BarclayLyonsMember COWI:CorowareIncAndSubsidiariesMember 2011-03-14 2011-03-15 0001156784 COWI:BarclayLyonsMember COWI:CorowareIncAndSubsidiariesMember 2011-03-15 0001156784 COWI:JohnKroonMember COWI:CorowareIncAndSubsidiariesMember 2010-03-16 2010-03-17 0001156784 COWI:JohnKroonMember COWI:CorowareIncAndSubsidiariesMember 2010-03-17 0001156784 COWI:WalterJayBellMember COWI:CorowareIncAndSubsidiariesMember 2013-10-17 2013-10-18 0001156784 COWI:WalterJayBellMember COWI:CorowareIncAndSubsidiariesMember 2013-10-18 0001156784 COWI:WalterJayBell1Member COWI:CorowareIncAndSubsidiariesMember 2016-04-23 2016-04-24 0001156784 COWI:WalterJayBell1Member COWI:CorowareIncAndSubsidiariesMember 2016-04-24 0001156784 COWI:GeorgeFerchMember COWI:CorowareIncAndSubsidiariesMember 2011-03-28 2011-03-29 0001156784 COWI:GeorgeFerchMember COWI:CorowareIncAndSubsidiariesMember 2011-03-29 0001156784 COWI:BlackbridgeLlcMember COWI:CorowareIncAndSubsidiariesMember 2012-04-10 2012-04-11 0001156784 COWI:BlackbridgeLlcMember COWI:CorowareIncAndSubsidiariesMember 2012-04-11 0001156784 COWI:MichaelSobeckMember COWI:CorowareIncAndSubsidiariesMember 2022-08-15 2022-08-16 0001156784 COWI:MichaelSobeckMember COWI:CorowareIncAndSubsidiariesMember 2022-08-16 0001156784 srt:MinimumMember 2023-01-01 2023-03-31 0001156784 srt:MaximumMember 2023-01-01 2023-03-31 0001156784 2002-04-01 2002-04-17 0001156784 2002-04-17 0001156784 2010-11-01 2010-11-30 0001156784 2011-11-01 2011-11-30 0001156784 us-gaap:MeasurementInputRiskFreeInterestRateMember 2023-03-31 0001156784 us-gaap:MeasurementInputRiskFreeInterestRateMember 2022-12-31 0001156784 us-gaap:MeasurementInputExpectedTermMember srt:MinimumMember 2023-01-01 2023-03-31 0001156784 us-gaap:MeasurementInputExpectedTermMember srt:MaximumMember 2023-01-01 2023-03-31 0001156784 us-gaap:MeasurementInputExpectedTermMember srt:MinimumMember 2022-01-01 2022-12-31 0001156784 us-gaap:MeasurementInputExpectedTermMember srt:MaximumMember 2022-01-01 2022-12-31 0001156784 us-gaap:MeasurementInputExpectedDividendRateMember 2023-03-31 0001156784 us-gaap:MeasurementInputExpectedDividendRateMember 2022-12-31 0001156784 us-gaap:MeasurementInputPriceVolatilityMember 2023-03-31 0001156784 us-gaap:MeasurementInputPriceVolatilityMember 2022-12-31 0001156784 2021-01-01 2021-12-31 0001156784 us-gaap:SeriesAPreferredStockMember 2023-03-31 0001156784 us-gaap:SeriesAPreferredStockMember 2023-01-01 2023-03-31 0001156784 us-gaap:SeriesAPreferredStockMember 2022-12-31 0001156784 us-gaap:SeriesBPreferredStockMember 2023-03-31 0001156784 us-gaap:SeriesBPreferredStockMember 2022-12-31 0001156784 us-gaap:SeriesBPreferredStockMember 2022-01-01 2022-03-31 0001156784 us-gaap:SeriesCPreferredStockMember 2023-03-31 0001156784 us-gaap:SeriesCPreferredStockMember 2023-01-01 2023-03-31 0001156784 us-gaap:SeriesCPreferredStockMember 2022-12-31 0001156784 us-gaap:SeriesDPreferredStockMember 2011-11-10 0001156784 us-gaap:SeriesDPreferredStockMember 2011-11-09 2011-11-10 0001156784 us-gaap:SeriesDPreferredStockMember 2023-03-31 0001156784 us-gaap:SeriesDPreferredStockMember 2022-12-31 0001156784 us-gaap:SeriesDPreferredStockMember 2023-01-01 2023-03-31 0001156784 us-gaap:SeriesDPreferredStockMember 2022-01-01 2022-03-31 0001156784 us-gaap:SeriesEPreferredStockMember 2012-03-09 0001156784 us-gaap:SeriesEPreferredStockMember 2012-03-09 2012-03-09 0001156784 us-gaap:SeriesEPreferredStockMember 2023-03-31 0001156784 us-gaap:SeriesEPreferredStockMember 2022-12-31 0001156784 us-gaap:SeriesEPreferredStockMember 2023-01-01 2023-03-31 0001156784 us-gaap:SeriesEPreferredStockMember 2022-01-01 2022-03-31 0001156784 us-gaap:SeriesFPreferredStockMember 2013-10-04 0001156784 us-gaap:SeriesFPreferredStockMember 2013-10-03 2013-10-04 0001156784 us-gaap:SeriesFPreferredStockMember 2023-03-31 0001156784 us-gaap:SeriesFPreferredStockMember 2022-12-31 0001156784 us-gaap:SeriesFPreferredStockMember 2023-01-01 2023-03-31 0001156784 us-gaap:SeriesFPreferredStockMember 2022-01-01 2022-03-31 0001156784 us-gaap:SeriesGPreferredStockMember 2014-04-17 0001156784 us-gaap:SeriesGPreferredStockMember 2014-04-16 2014-04-17 0001156784 us-gaap:SeriesGPreferredStockMember 2023-03-31 0001156784 us-gaap:SeriesGPreferredStockMember 2022-12-31 0001156784 us-gaap:SeriesGPreferredStockMember 2023-01-01 2023-03-31 0001156784 us-gaap:SeriesGPreferredStockMember 2022-01-01 2022-03-31 0001156784 COWI:LloydSpencerMember 2023-01-25 2023-01-25 0001156784 COWI:LloydSpencerMember 2023-01-25 0001156784 COWI:BHPCapitalNYIncMember 2023-02-15 2023-02-15 0001156784 COWI:BHPCapitalNYIncMember 2023-02-15 0001156784 COWI:TheStreetGroupLLCMember 2023-03-03 2023-03-03 0001156784 COWI:MutualReleaseAndSettlementAgreementWithYAGlobalInvestmentLPMember 2022-01-20 2022-01-21 0001156784 COWI:LloydSpencerMember 2022-01-20 2022-01-21 0001156784 COWI:SalvumCorporationMember 2022-02-13 2022-02-14 0001156784 COWI:LloydSpencerMember 2022-02-13 2022-02-14 0001156784 COWI:CarbonMetaResearchLtdMember 2022-02-13 2022-02-14 0001156784 COWI:CarbonMetaResearchLtdMember COWI:ThreeOtherIndividualsMember 2022-02-13 2022-02-14 0001156784 COWI:EcomenaLimitedMember 2022-02-16 2022-02-17 0001156784 COWI:LloydSpencerMember 2022-03-06 2022-03-07 0001156784 COWI:TangiersInvestmentGroupLLCMember 2022-03-20 2022-03-21 0001156784 COWI:BillElderMember 2022-04-04 2022-04-04 0001156784 COWI:MacRabLLCMember 2022-05-09 2022-05-10 0001156784 COWI:BHPCapitalNYIncMember 2022-07-13 2022-07-14 0001156784 COWI:QuickCapitalLLCMember 2022-07-13 2022-07-14 0001156784 COWI:RPGCapitalPartnersIncMember 2022-08-03 2022-08-04 0001156784 COWI:RPGCapitalPartnersIncMember 2022-09-11 2022-09-12 0001156784 COWI:RPGCapitalPartnersIncMember 2022-11-06 2022-11-07 0001156784 COWI:RobertPapirMember 2022-11-15 2022-11-16 0001156784 COWI:LloydSpencerMember COWI:TransactionTwoMember 2023-03-31 0001156784 COWI:LloydSpencerMember 2023-01-01 2023-03-31 0001156784 COWI:TangiersInvestmentGroupLLCMember 2023-01-01 2023-03-31 0001156784 COWI:JHDarbieAndCompanyMember 2023-01-01 2023-03-31 0001156784 COWI:MacRabLLCOneMember 2023-01-01 2023-03-31 0001156784 COWI:MacRabLLRTwoMember 2023-01-01 2023-03-31 0001156784 COWI:BHPCapitalNYIncMember 2023-01-01 2023-03-31 0001156784 COWI:QuickCapitalLLCMember 2023-01-01 2023-03-31 0001156784 COWI:RobertPapiriDefinedBenefitPlanMember 2023-01-01 2023-03-31 0001156784 COWI:RobertPapiriDefinedContributionPlanMember 2023-01-01 2023-03-31 0001156784 COWI:RPGCapitalPartnersIncMember 2023-01-01 2023-03-31 0001156784 COWI:RPGCapitalPartnersIncOneMember 2023-01-01 2023-03-31 0001156784 COWI:RPGCapitalPartnersIncTwoMember 2023-01-01 2023-03-31 0001156784 COWI:LloydSpencerMember 2022-03-07 2022-03-07 0001156784 COWI:LloydSpencerMember 2022-03-07 0001156784 COWI:TangiersInvestmentGroupMember 2022-03-20 2022-03-21 0001156784 COWI:TangiersInvestmentGroupMember 2022-03-21 0001156784 COWI:JHDarbieAndCompanyMember COWI:PlacementAgentAgreementMember 2022-02-23 0001156784 COWI:StandbyEquityCommitmentAgreementMember COWI:MacRabLLCMember 2022-04-13 2022-04-14 0001156784 COWI:StandbyEquityCommitmentAgreementMember COWI:MacRabLLCMember 2022-04-14 0001156784 COWI:MacRabLLCMember COWI:FixedConvertiblePromissoryNoteMember 2022-05-09 2022-05-10 0001156784 COWI:MacRabLLCMember COWI:FixedConvertiblePromissoryNoteMember 2022-05-10 0001156784 COWI:BHPCapitalNYIncMember COWI:FixedConvertiblePromissoryNoteMember 2022-07-13 2022-07-14 0001156784 COWI:BHPCapitalNYIncMember COWI:FixedConvertiblePromissoryNoteMember 2022-07-14 0001156784 COWI:QuickCapitalLLCMember COWI:FixedConvertiblePromissoryNoteMember 2022-07-13 2022-07-14 0001156784 COWI:QuickCapitalLLCMember COWI:FixedConvertiblePromissoryNoteMember 2022-07-14 0001156784 COWI:RobertPapiriDefinedBenefitPlanMember COWI:FixedConvertiblePromissoryNoteMember 2022-07-13 2022-07-15 0001156784 COWI:RobertPapiriDefinedBenefitPlanMember COWI:FixedConvertiblePromissoryNoteMember 2022-07-15 0001156784 COWI:RobertPapiriDefinedContributionPlanMember COWI:FixedConvertiblePromissoryNoteMember 2022-07-13 2022-07-15 0001156784 COWI:RobertPapiriDefinedContributionPlanMember COWI:FixedConvertiblePromissoryNoteMember 2022-07-15 0001156784 COWI:RPGCapitalPartnersIncMember COWI:FixedConvertiblePromissoryNoteMember 2022-07-13 2022-07-15 0001156784 COWI:RPGCapitalPartnersIncMember COWI:FixedConvertiblePromissoryNoteMember 2022-07-15 0001156784 COWI:RPGCapitalPartnersIncMember COWI:FixedConvertiblePromissoryNoteMember 2022-08-03 2022-08-04 0001156784 COWI:RPGCapitalPartnersIncMember COWI:FixedConvertiblePromissoryNoteMember 2022-08-04 0001156784 COWI:RPGCapitalPartnersIncMember COWI:FixedConvertiblePromissoryNoteMember 2022-09-11 2022-09-12 0001156784 COWI:RPGCapitalPartnersIncMember COWI:FixedConvertiblePromissoryNoteMember 2022-09-12 0001156784 COWI:EmploymentAgreementMember COWI:LloydTSpencerMember 2006-05-12 2006-05-13 0001156784 COWI:OneCustomerMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-03-31 0001156784 COWI:CarbonMetaResearchIndiaMember srt:ParentCompanyMember us-gaap:SubsequentEventMember 2023-04-08 0001156784 COWI:CarbonMetaResearchIndiaMember COWI:FermionElectricPrivateLimitedMember us-gaap:SubsequentEventMember 2023-04-08 0001156784 COWI:CarbonMetaGreenResourcesCanadaMember srt:ParentCompanyMember us-gaap:SubsequentEventMember 2023-04-21 0001156784 COWI:CarbonMetaGreenResourcesCanadaMember COWI:NorthBayResourcesIncMember us-gaap:SubsequentEventMember 2023-04-21 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure COWI:Segment utr:D utr:Y iso4217:EUR

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended March 31, 2023

 

or

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from ________ to ________

 

Commission file number: 000-33231

 

CARBONMETA TECHNOLOGIES, INC.

(Exact Name of Registrant as Specified in its Charter)

 

Delaware   95-4868120
(State or Other Jurisdiction   (I.R.S. Employer
of Incorporation or Organization)   Identification No.)

 

13110 NE 177th Place, Suite 145    
Woodinville, WA   98072
(Address of Principal Executive Offices)   (Zip Code)

 

(844) 698-3777

(Registrant’s Telephone Number, Including Area Code)

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or Section 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

 

Yes ☐ No

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).

 

Yes ☐ No

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer ☐ Accelerated filer ☐
Non-accelerated filer Smaller Reporting Company
  Emerging Growth Company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. ☐

 

Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to §240.10D-1(b). ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

 

☐ Yes ☒ No

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock, $0.001 par value per share   COWI   OTC Markets “PINK”

 

As of May 19, 2023, there were 19,172,538,816 shares of the registrant’s common stock outstanding.

 

 

 

 
 

 

CARBONMETA TECHNOLOGIES, INC.

 

TABLE OF CONTENTS

 

    Page Number
     
PART I   5
Item 1. Financial Statements 5
  Condensed Consolidated Balance Sheets as of March 31, 2023 (Unaudited) and December 31, 2022 5
  Condensed Consolidated Statements of Operations for the three months ended March 31, 2023 and 2022 (Unaudited) 6
  Condensed Consolidated Statements of Changes in Stockholders’ (Deficit) for the three months ended March 31, 2023 and 2022 (Unaudited) 7
  Condensed Consolidated Statements of Cash Flows for the three months ended March 31, 2023 and 2022 (Unaudited) 8
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 31
Item 3. Quantitative and Qualitative Disclosures About Market Risk 38
Item 4. Controls and Procedures 38
     
PART II  
Item 1. Legal Proceedings 39
Item 1A. Risk Factors 39
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 39
Item 3. Defaults Upon Senior Securities 39
Item 4. Mine Safety Disclosures 39
Item 5. Other Information 39
Item 6. Exhibits 40
     
  Signatures 44

 

2
 

 

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

 

This Quarterly Report on Form 10-Q for the period ended March 31, 2023 (the “Quarterly Report”) contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). These statements relate to future events including, without limitation, our ability to raise capital, our operational and strategic initiatives or our future financial performance. We have attempted to identify forward-looking statements by using terminology such as “anticipates,” “believes,” “expects,” “can,” “continue,” “could,” “estimates,” “expects,” “intends,” “may,” “plans,” “potential,” “predict,” “should” or “will” or the negative of these terms or other comparable terminology. These statements are only predictions; uncertainties and other factors may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels or activity, performance or achievements expressed or implied by these forward-looking statements. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance or achievements. Our expectations are as of the date this Quarterly Report is filed, and we do not intend to update any of the forward-looking statements after the date this Quarterly Report is filed to confirm these statements to actual results, unless required by law.

 

You should not place undue reliance on forward-looking statements. The cautionary statements set forth in this Quarterly Report identify important factors which you should consider in evaluating our forward-looking statements. These factors include, among other things:

 

  Our ability to effectively execute our business plans including transitioning from being focused on end-to-end consumer product innovation, development, and commercialization to being focused on digital media, advertising and content technologies innovation, development, and commercialization;
  Our ability to manage our expansion, growth and operating expenses;
  Our ability to protect our brands, reputation and intellectual property rights;
  Our ability to obtain adequate financing to support our development plans;
  Our ability to repay our debts;
  Our ability to rely on third-party suppliers, content contributors, developers, and other business partners;
  Our ability to evaluate and measure our business, prospects and performance metrics;
  Our ability to compete and succeed in a highly competitive and evolving industry;
  Our ability to respond and adapt to changes in technology and consumer behavior;
  Our dependence on information technology, and being subject to potential cyberattacks, security problems, network disruptions, and other incidents;
  Our ability to comply with complex and evolving laws and regulations including those relating to privacy, data use and data protection, content, competition, safety and consumer protection, e-commerce, digital assets and other matters, many of which are subject to change and uncertain interpretation;
  Our ability to enhance disclosure and financial reporting controls and procedures and remedy the existing weakness;
  Risks in connection with completed or potential acquisitions, dispositions and other strategic growth opportunities and initiatives;
  Taxes;
  The stability of the governments and political and business conditions in certain foreign countries in which we or certain of our business partners may operate now or in the future;
  Costs and results of potential litigation;
  Changes in accounting standards or inaccurate estimates or assumptions in the application of accounting policies;
  The use of social or digital media to disseminate false, misleading and/or unreliable or inaccurate information regarding our products, services or the industry in which we operate;
  Other risk factors discussed in our Annual Report on Form 10-K filed with the Securities and Exchange Commission on April 20, 2023.

 

These and other factors discussed above could cause results to differ materially from those expressed in the estimates made by any independent parties and by us.

 

3
 

 

TRADEMARKS, SERVICE MARKS AND TRADE NAMES

 

Solely for convenience, we refer to trademarks in this Quarterly Report without the ® or the ™ or symbols, but such references are not intended to indicate that we will not assert, to the fullest extent under applicable law, our rights to our own trademarks. Other service marks, trademarks and trade names referred to in this Quarterly Report, if any, are the property of their respective owners, although for presentational convenience we may not use the ® or the ™ symbols to identify such trademarks.

 

OTHER PERTINENT INFORMATION

 

Unless the context otherwise indicates, when used in this Annual Report, the terms “CarbonMeta,” “COWI,” “we,” “us,” “our,” the “Company” and similar terms refer to CarbonMeta Technologies, Inc., a Delaware corporation, and all of our consolidated subsidiaries and variable interest entities.

 

4
 

 

PART I - FINANCIAL INFORMATION

 

CARBONMETA TECHNOLOGIES, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

 

   March 31,   December 31, 
   2023   2022 
   (Unaudited)      
ASSETS          
           
CURRENT ASSETS:          
Cash  $5,096   $379 
Accounts receivable   

-

    20,525 
Inventory   

3,157

    

3,157

 
Total Current Assets   8,253    24,061 
           
Property and equipment, net of accumulated depreciation of $22,065 and $18,235 at March 31, 2023 and December 31, 2022, respectively   25,059    28,889 
Licenses, net of accumulated amortization of $38,683 and $32,229 at March 31, 2023 and December 31, 2022, respectively   131,820    138,274 
TOTAL ASSETS  $165,132   $191,224 
           
LIABILITIES AND STOCKHOLDERS’ DEFICIT          
           
CURRENT LIABILITIES:          
Accounts payable and accrued expenses  $11,777,941   $11,457,444 
Obligations collateralized by receivables   206,236    206,236 
Convertible debt, net   2,164,529    2,160,034 
Notes payable   154,873    154,873 
Notes payable - related parties   199,415    199,415 
Small Business Administration loan   979,950    979,950 
Derivative liability   18,009,660    9,652,846 
Total Current Liabilities   33,492,604    24,810,798 
TOTAL LIABILITIES  $33,492,604   $24,810,798 
           
Commitments and contingencies   -    - 
           
STOCKHOLDERS’ DEFICIT:          
Redeemable convertible preferred stock, Series A, $0.001 par value, 125,000 shares authorized, 0 shares issued and outstanding   -    - 
Redeemable convertible preferred stock, Series B, $0.001 par value, 525,000 shares authorized, 159,666 and 159,666 shares issued and outstanding   160    160 
Redeemable convertible preferred stock, Series C, $0.001 par value, 500,000 shares authorized, 0 and 0 shares issued and outstanding   -    - 
Redeemable convertible preferred stock, Series D, $0.001 par value, 500,000 shares authorized, 100,000 and 100,000 shares issued and outstanding   100    100 
Redeemable convertible preferred stock, Series E, $0.001 par value, 1,000,000 shares authorized, 821,377 and 821,377 shares issued and outstanding, respectively   821    821 
Redeemable convertible preferred stock, Series F, $0.001 par value, 500,000 shares authorized, 190,000 and 190,000 shares issued and outstanding   190    190 
Redeemable convertible preferred stock, Series G, $0.001 par value, 500,000 shares authorized, 25,000 and 25,000 shares issued and outstanding   25    25 
Common stock; 35,000,000,000 and 35,000,000,000 shares authorized at $0.0001 par value, 19,360,719,816 and 18,831,386,254 shares issued, respectively; 19,245,422,812 and 18,643,205,254 shares outstanding, respectively   1,936,072    1,883,139 
Additional paid-in capital   37,558,582    37,515,219 
Treasury stock – 115,297,004 and 188,181,000 shares of common stock   (14,230)   (18,997)
Accumulated other comprehensive income   

2,670

    3,725 
Accumulated deficit   (72,811,862)   (64,003,956)
TOTAL STOCKHOLDERS’ DEFICIT   (33,327,472)   (24,619,574)
TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT  $165,132   $191,224 

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

5
 

 

CARBONMETA TECHNOLOGIES, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME

For the three months ended March 31, 2023 and 2022

 

  

March 31,

2023

  

March 31,

2022

 
   (Unaudited)   (Unaudited) 
Contract services revenue  $10,376   $- 
           
Operating expenses:          
Executive compensation   37,500    37,500 
Legal and professional fees   23,161    44,056 
Investor relations   4,090    20,664 
Consulting fees   

1,288

    15,221 
Sales and marketing   

20,000

    14,183 
Research and development   

9,330

    4,099 
Amortization of licenses   6,454    7,904 
Depreciation of equipment   3,830    3,830 
Other operating expenses   26,372    110,057 
Total operating expenses   132,025    257,514 
           
Operating (loss)   (121,649)   (257,514)
           
Other income (expenses):          
Gain (loss) from derivative liability   (8,356,814)   (571,095)
Interest expense   (329,443)   (220,928)
Total other income (expenses) - net   (8,686,257)   (792,023)
           
Income (loss) before income taxes   (8,807,906)   (1,049,537)
Income tax provision   -    - 
Net income (loss)  $(8,807,906)  $(1,049,537)
           
Net income per common share:          
Basic  $(0.00)  $(0.00 )
Diluted  $(0.00)  $(0.00 )
Weighted-average common shares outstanding:          
Basic   

19,110,654,882

    

18,285,313,740

 
Diluted   

19,110,654,882

    

18,285,313,740

 
Comprehensive income (loss):          
Net income (loss)  $

(8,807,906

)  $

(1,049,537

)

Foreign currency translation adjustments

   

(1,055

)   - 
Comprehensive income (loss)  $

(8,808,961

)  $

(1,049,537

)

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

6
 

 

CARBONMETA TECHNOLOGIES, INC.

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ (DEFICIT)

For the three months ended March 31, 2023 and 2022

(Unaudited)

 

   Series B   Series D   Series E   Series F   Series G   Amount   Shares   Amount  

Paid-In

Capital

   Stock   Deficit   Comprehensive Income   Total 
   Preferred Stock   Common Stock   Additional         Accumulated Other     
   Series B   Series D   Series E   Series F   Series G   Amount   Shares   Amount  

Paid-In

Capital

   Treasury
Stock
   Accumulated
Deficit
   Comprehensive Income   Total 
                                                     
Balances, December 31, 2021   159,666    100,000    791,567    180,000    25,000   $1,256    17,592,057,165   $1,759,206   $36,775,736   $(18,997)  $(64,404,388)   -   $(25,887,187)
Common stock issued for license   -    -    -    -    -    -    160,000,000    16,000    48,000    -    -    -    64,000 
Common stock issued for services   -    -    -    -    -    -    203,333,334    20,333    52,667    -    -    -    73,000 
Common stock and warrants issued in connection with convertible notes financings, net of placement agent fee of $1,350   -    -    -    -    -    -    60,500,000    6,050    102,600    -    -    -    108,650 
Common stock issued for accrued executive compensation   -    -    -    -    -    -    428,571,428    42,857    107,143    -    -    -     150,000 
Common stock issued for accrued consulting fees   -    -    -    -    -    -    206,896,552    20,690    279,310    -    -    -     300,000 
Net loss for three months ended March 31, 2022   -    -    -    -    -    -    -    -    -    -    (1,049,537)   -    (1,049,537)
Balances, March 31, 2022   159,666    100,000    741,567    180,000    25,000   $1,256    18,651,358,479   $1,865,136   $37,365,456   $(18,997)  $(65,453,925)   $

-

   $(26,241,074)
                                                                  
Balances, December 31, 2022   159,666    100,000    821,377    190,000    25,000   $1,296    

18,831,386,254

   $1,883,139   $37,515,219   $(18,997)  $(64,003,956)  $3,725   $(24,619,574)
Common stock issued in connection with conversion of convertible notes   -    -    -    -    -    -    329,333,562    32,933    32,933    -    -    -    65,866 
Common stock issued for services   -    -    -    -    -    -    200,000,000    20,000    -    -    -    -    20,000 
Sale of Treasury stock   -    -    -    -    -    -    -    -    10,430    4,767    -    -    15,197 
Foreign currency translation adjustments   -    -    -    -    -    -    -    -    -    -    -    (1,055)   (1,055)
Net loss for three months ended March 31, 2023   -    -    -    -    -    -    -    -    -    -    (8,807,906)   -    (8,807,906)
Balances, March 31, 2023   159,666    100,000    821,377    190,000    25,000   $1,296    19,360,719,816   $1,936,072   $37,558,582   $(14,230)  $(72,811,862)  $2,670   $(33,327,472)

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

7
 

 

CARBONMETA TECHNOLOGIES, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

For the three months ended March 31, 2023 and 2022

 

   March 31, 2023   March 31, 2022 
   (Unaudited)   (Unaudited) 
OPERATING ACTIVITIES:          
Net income (loss) for the period  $(8,807,906)  $(1,049,537)
Adjustments to reconcile net income (loss) to net cash used in operating activities:          
Depreciation of equipment   3,830    3,830 
Amortization of licenses   6,454    7,904 
Amortization of debt discounts   64,195    8,313 
Stock based compensation   24,249    48,000 
Loss (gain) from derivative liability   8,356,814    571,095 
Changes in operating assets and liabilities:          
Accounts receivable   20,525    - 
Prepaid expenses   -    33,611 
Accounts payable and accrued expenses   322,414    312,759 
NET CASH (USED IN) OPERATING ACTIVITIES   (9,425)   (64,025)
           
INVESTING ACTIVITIES:          
Purchase of equipment   -    - 
NET CASH USED IN INVESTING ACTIVITIES   -    - 
           
FINANCING ACTIVITIES:          
Proceeds from convertible debt financings   -    108,650 
Proceeds from sales of treasury stock   15,197    - 
Payments towards notes payable   -    (3,000)
NET CASH PROVIDED BY FINANCING ACTIVITIES   15,197    105,650 
           
EXCHANGE RATE EFFECT ON CASH   (1,055)   - 
           
NET INCREASE (DECREASE) IN CASH   4,717    41,625 
CASH, BEGINNING OF PERIOD   379    10,573 
CASH, END OF PERIOD  $5,096   $51,198 
           
SUPPLEMENTAL CASH FLOW INFORMATION:          
Cash paid during the year for:          
Interest  $-   $- 
Income taxes  $-   $- 
SUPPLEMENTAL DISCLOSURE OF NON-CASH FINANCING ACTIVITIES:          
Common Stock issued in satisfaction of accrued executive compensation  $-   $150,000 
Common Stock issued for accrued consulting fees  $-   $300,000 
Common stock issued for prepaid marketing fees  $-   $

25,000

 
Common stock issued for license  $-   $

64,000

 
Common stock and warrants issued in connection with new convertible notes  $-   $

110,000

 

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

8
 

 

CARBONMETA TECHNOLOGIES, INC.

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

For the three months ended March 31, 2023 and 2022

(Unaudited)

 

NOTE A – ORGANIZATION

 

CarbonMeta Technologies, Inc. (f/k/a CoroWare, Inc.) (“CarbonMeta”, the “Company”, “we”, “us”, or “our”) is a publicly quoted environmental research and development company that is commercializing technologies for processing organic wastes into hydrogen and high-value carbon products economically and sustainably.

 

The Company was incorporated on June 8, 2001 under the laws of the State of Nevada as SRM Networks, Inc. In connection with the acquisition of Hy-Tech Computer Systems, Inc. on January 31, 2003, the Company changed its name to Hy-Tech Technology Group, Inc. In connection with the Agreement and Plan of Merger of Robotics Workspace Technology, Inc., Innova Holdings, Inc. and the Company’s wholly owned subsidiary, RWT Acquisition, Inc., dated July 21, 2004, the Company’s name changed to Innova Holdings, Inc. Subsequently, the Company redomiciled in the State of Delaware and on November 20, 2006, the Company changed its name to Innova Robotics and Automation, Inc. and then on April 23, 2008, the Company changed its name to CoroWare, Inc. On or about July 28, 2021, the Company filed Articles of Amendment to its Amended and Restated Certificate of Incorporation with the State of Delaware to reflect a name change from CoroWare, Inc. to CarbonMeta Technologies, Inc.

 

The Company has six wholly-owned subsidiaries: CoroWare Technologies, Inc. (“CTI”), CoroWare Robotics Solutions, Inc. (“CRS”), Robotic Workspace Technologies, Inc. (“RWT”), Carbon Source, Inc. (“CS”), CoroWare Treasury, Inc. (“CWT”), and CarbonMeta Research Ltd. (“CMR”). The Company has two majority owned subsidiaries: a 50.1% interest in CarbonMeta Green Building Materials, LLC (joint venture with Salvum Corporation)(“CMGBM”) and a 51% interest in AriCon, LLC (“AriCon”).

 

CoroWare Technologies, Inc. (“CTI”) was incorporated in the State of Florida on May 16, 2006, was administratively dissolved on November 19, 2016, and its principal business was a software professional services company with a strong focus on information technology integration and robotics integration, business automation solutions, and unmanned systems solutions to its customers in North America and Europe.

 

CoroWare Robotics Solutions, Inc. (“CRS”) was incorporated in the State of Texas on February 27, 2015, and its principal business was as a technology incubation company whose focus was on the delivery of mobile robotics and IOT products, solutions and services for university, government and corporate researchers, and enterprise customers. CRS’s business operations were discontinued in October 2016 when the Company’s gross margins and financing costs became unsustainable.

 

Robotic Workspace Technologies, Inc. (“RWT”) was incorporated in the State of Florida on July 1, 1994, was administratively dissolved on September 25, 2009, and its principal business was developing and marketing open-architecture PC controls and related products that could improve the performance, applicability, and productivity of robots and other automated equipment. RWT’s business operations were discontinued in September 2007 when the Company’s losses became unsustainable.

 

Carbon Source, Inc. (“CS”) was incorporated in the State of Wyoming on June 14, 2021 and its principal business is waste reclamation technologies and processing.

 

CoroWare Treasury, Inc. (“CWT”) was incorporated in the State of Wyoming on July 8, 2021 and its principal business is acquisitions related to acquiring technologies and subsidiary businesses related to waste processing.

 

CarbonMeta Research Ltd. (‘CMR”) was incorporated in England and Wales on August 12, 2021 and its principal business is the development of technologies and solutions for processing organic wastes and generating economically sustainable hydrogen and high-value carbon products. Using proprietary and patented technologies, it plans to implement new industrial methods using inexpensive, environmentally friendly catalysts that process collected plastic waste material into high value products such as hydrogen gas, graphene and carbon nanotubes.

 

CarbonMeta Green Building Materials, LLC (“CMGBM”) is a joint venture with Salvum Corporation organized on August 30, 2022 to develop and market construction mix products that are carbon negative (see Production Agreement below).

 

AriCon, LLC (“AriCon”) was a joint venture that was intended to develop mobile robot platforms, applications, and solutions for the construction industry. In October 2016, AriCon ceased operations of all subsidiary business operations when the Company’s losses became unsustainable, and the Company was not able to obtain investment financing.

 

In 2021, the Company began investigating emerging technologies, strategic intellectual property partnerships, and sustainable growth business opportunities related to the production of hydrogen and high value carbon products from organic waste streams. Working cooperatively with Oxford University Innovation, CarbonMeta plans to implement proven and patented technologies to add value to organic waste streams. By utilizing these proven proprietary technologies, collected and captured plastic waste material can be upcycled to high value products such as carbon nanotubes (“CNTs”) and hydrogen gas.

 

9
 

 

CARBONMETA TECHNOLOGIES, INC.

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

For the three months ended March 31, 2023 and 2022

(Unaudited)

 

NOTE A – ORGANIZATION (continued)

 

CNTs can be used for improved electrical conduction and reinforcing materials that are used in a wide variety of industries including the automotive industry, aviation industry, medical industry, and construction. The number one growth driver is the increasing need for high performance batteries for the electric vehicle market.

 

Plastic waste is a cheap and abundant feedstock that will allow the Company to scale quickly and produce hydrogen gas for a competitive price.

 

License Agreements

 

Oxford University Innovation Limited

 

On June 2, 2021, the Company (the “Licensee”) entered into a License Agreement (the “Agreement”) with Oxford University Innovation Limited (the “Licensor”). Under the terms of the Agreement, the Licensee will license the licensed technology (OUI Project- Hydrogen from plastics via microwave-initiated catalytic dehydrogenation). The Agreement is non-exclusive and includes the United States and European Union. Signing fees for the Agreement were £54,807 and have been paid in full by the Company. The Royalty Rate is 5% of net sales. The Agreement comprises milestone fees as: (i) £20,000 upon the first commercial sale of a licensed product; (ii) £50,000 upon generating $1,000,000 in sales; (iii) £10,000 upon the successful grant of the US patent; and (iv) £10,000 upon the successful grant of the EU patent. Whether the company realizes product sales or not, the Company is subject to a minimum payment to Oxford University Innovation of £10,000 for license year 3 and £20,000 for license year 4 and each license year thereafter.

 

The process that the Company licensed from Licensor for producing hydrogen and carbon products from waste plastics has not been demonstrated on a larger scale. It is not yet known whether the process will be cost-effective or profitable to implement on a larger scale. The Company has conducted tests to prove the percentage of carbon nanotubes up to 10 grams. The Company is working with a microwave reactor company to help demonstrate this process at a scale of 100 kilograms and 1,000 kilograms per day.

 

The Company has met the following milestones of its development plan set forth in the license agreement with Oxford University Innovation:

 

  September 2021: established subsidiary in Oxford, United Kingdom
  March 2022: produced 0.025 kilograms per day of marketable carbon nanotubes

 

Oxford University Innovation may terminate the license due to the company not using commercially reasonable efforts to develop, exploit and market the licensed technology in accordance with the development plan.

 

From July 2022 to present (see Service Award below), CarbonMeta Technologies has been working with University of Oxford on a project with a global multi-energy provider based in Europe to assess the feasibility of processing mixed plastic waste into clean hydrogen fuel and value-added carbon products using microwave catalysis on a large commercial scale.

 

Ecomena Limited

 

On December 2, 2021, the Company (“Licensee”) entered into a License of Agreement (the “Agreement”) with Ecomena Limited (an entity located in the United Kingdom) (“Licensor”). Under the terms of the Agreement, the Licensee will license the Licensed Technology to recycle industrial byproduct into cement free pavers and mortars that are environmentally friendly and continuously absorb carbon dioxide. The signing fees payable to the Licensor under the Agreement are £20,000 cash (approximately $27,247 at February 17, 2022), of which £10,000 has been paid by the Licensee, and 160,000,000 shares of the Company’s common stock, which was delivered to the Licensor on February 17, 2022. The royalty rate payable to the Licensor is 5% of net sales, subject to a minimum of £5,000 per year for license years 1 and 2, £3,000 for license year 3 and £1,000 for license year 4 and each license year thereafter. The term of the Agreement is five years from December 2, 2021 to December 2, 2026. The Licensee may terminate the Agreement for any reason at any time provided it gives Licensor six (6) months written notice to terminate expiring after December 2, 2024. If requested by the Licensee, the Licensor shall agree to the Agreement continuing in force after December 2, 2026. As of the date of this filing, the Agreement is still in effect.

 

10
 

 

CARBONMETA TECHNOLOGIES, INC.

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

For the three months ended March 31, 2023 and 2022

(Unaudited)

 

NOTE A – ORGANIZATION (continued)

 

Production Agreement

 

On January 11, 2022, the Company entered into an Interim Joint Product Development and Sales Representation Agreement (the “Agreement”) with Salvum Corporation. Under the terms of the Agreement, the parties agree to work together to develop both CarbonMeta’s proprietary cementless paver products known as “Cementless Paver” and Salvum’s proprietary concrete alternative products known as “EarthCrete.” During the Term, Salvum agrees to manufacture CarbonMeta’s proprietary cementless paver products known as “Cementless Paver”. CarbonMeta reserves the right to appoint other manufacturers of the products and/or to engage other sales representatives for CarbonMeta’s proprietary cementless paver products known as “Cementless Paver” outside the United States of America. Although the Interim Joint Product Development and Sales Representation Agreement with Salvum Corporation had a term of 180 days and expired on July 11, 2022, the companies continued to work together, and the companies formed CarbonMeta Green Building Materials, LLC (“CMGBM”) and signed an Operating Agreement for Management of CMGBM on August 28, 2022 that supersedes the Interim Joint Product Development and Sales Representation Agreement.

 

The Operating Agreement for Management of CMGBM (the “CMGBM Agreement”) provides for (1) the allocation of 501 Managing Membership units (50.1%) to CarbonMeta Technologies, Inc. (“COWI”) and 499 Managing Membership units (49.9%) to Salvum Corporation, (2) COWI capital contributions to CMGBM of (a) 250,000,000 shares of COWI common stock and (b) the assignment of the Ecomena Limited license agreement, and (3) Salvum Corporation capital contributions to CMGBM of (a) existing EarthCrete customer list and sales pipeline, and (b) license to use EarthCrete trademark worldwide. The CMGBM Agreement also provides that profits and losses (and distributions) of CMGBM shall be allocated on the basis of each Managing Member’s relative capital accounts and that a Managing Member may withdraw from CMGBM upon not less than six months prior written notice to each non-withdrawing Managing Member. As of March 31, 2023, the above capital contributions provided for in the CMGBM Agreement had not occurred and no significant operations of CMGBM had commenced.

 

Service Award

 

On June 10, 2022, our subsidiary, CarbonMeta Research Ltd. (“CMR”), was granted a Service Award (entitled “Waste Plastic Catalysis Proof of Concept”) from a business company located in Spain. The award provided for CMR to provide the customer with an initial prototype process for converting mixed waste plastic to hydrogen and solid carbon and for the customer to pay CMR a total of 50,000 Euros in four installments as certain milestones are met. As of March 31, 2023, all of the milestones had been met by CMR and CMR had invoiced the customer the full 50,000 Euros ($49,542), of which $40,103 was collected in the third quarter 2022 and $9,439 was collected in the fourth quarter 2022.

 

In October 2022, CMR was granted a second Service Award for 50,000 Euros to provide the customer with further details on the composition of the carbon products resulting from the microwave catalysis of waste plastics.  In December 2022, CMR invoiced the customer for 20,000 Euros, which was collected in January 2023. The project is expected to reach completion in June 2023.

 

In order to further grow its business, the Company plans to:

 

  Develop and patent new microwave catalysis processes that can yield high value hydrogen and carbon products;
     
  Work closely with commercial building and solar farm general contractors that want to purchase “carbon negative” construction materials that can generate carbon credits;
     
  Acquire or develop patents that will help the Company generate royalty revenues with potential customers and partners, and protect the Company’s competitive position against potential competitors;
     
  Develop new proprietary and patented technologies to implement new industrial methods that can use inexpensive, environmentally friendly catalysts to process collected plastic waste material into high value products such as hydrogen gas, graphene and carbon nanotubes;
     
  seek out government programs in the United Kingdom, European Union and United States that encourage the development of high value production of hydrogen and high value carbon products from organic waste streams; and
     
  Attract investment funds who will actively work with the Company to achieve these goals and help the Company grow rapidly during the next 3 years.

 

11
 

 

CARBONMETA TECHNOLOGIES, INC.

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

For the three months ended March 31, 2023 and 2022

(Unaudited)

 

NOTE A – ORGANIZATION (continued)

 

Some potential joint venture candidates have been identified and discussions initiated. These candidates are within the Company’s core business model, serving commercial properties, accretive to cash flow, and geographically favorable. One of these joint ventures, CarbonMeta Green Building Materials LLC will be focused on the development at marketing of construction mix products that are carbon negative. Two other joint ventures under discussion are focused on processing waste plastics into hydrogen and high value carbon products. We plan to fund these joint ventures with customer purchase orders and invoice payments, federal loans, federal grants, and commercial loans.

 

We have unrestricted discretion in seeking and participating in a business opportunity, subject to the availability of such opportunities, economic conditions, and other factors.

 

The selection of a business opportunity in which to participate is complex and risky. Additionally, we have only limited resources and may find it difficult to locate good opportunities. There can be no assurance that we will be able to identify and acquire any business opportunity which will ultimately prove to be beneficial to us and our shareholders. We will select any potential business opportunity based on our management’s best business judgment.

 

Our activities are subject to several significant risks, which arise primarily as a result of the fact that we have no specific business and may acquire or participate in a business opportunity based on the decision of management, which potentially could act without the consent, vote, or approval of our shareholders. The risks faced by us are further increased as a result of our lack of resources and our inability to provide a prospective business opportunity with significant capital.

 

Principal Products or Services and Markets

 

The Company is in the business of developing and marketing technologies and solutions that can process organic and construction wastes into economically high-value and ecologically sustainable products.

 

The Company is partnering with a microwave reactor manufacturer in the United States to “scale up” the patented waste plastics microwave processes that the Company licensed from Oxford University Innovation, and with a university partner in the United States to separate, purify and characterize carbon nanotubes that the UK and US developers shall produce.

 

The principal products that the Company intends to market comprise:

 

  amorphous carbon, graphite, nano-graphite, graphene, carbon nanotubes, and hydrogen; and
  carbon-negative building products that help alleviate climate change by capturing carbon dioxide (CO2) for renewable energy projects.

 

12
 

 

CARBONMETA TECHNOLOGIES, INC.

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

For the three months ended March 31, 2023 and 2022

(Unaudited)

 

NOTE B – SIGNIFICANT ACCOUNTING POLICIES

 

Interim Financial Statements

 

The accompanying unaudited financial statements are presented in accordance with generally accepted accounting principles for interim financial information and the instructions to Form 10-Q and Article 8 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments (consisting only of normal recurring accruals) considered necessary in order to make the financial statements not misleading, have been included. Operating results for the three months ended March 31, 2023 are not necessarily indicative of results that may be expected for the year ending December 31, 2023. The balance sheet information as of December 31, 2022 was derived from the audited financial statements included in the Company’s Annual Report on Form 10-K filed with the Securities and Exchange Commission on April 20, 2023. These financial statements should be read in conjunction with that report.

 

Principles of Consolidation

 

The consolidated financial statements include the accounts of CarbonMeta Technologies, Inc. and its six wholly-owned subsidiaries, CoroWare Technologies, Inc., CoroWare Robotics Solutions, Inc., Robotic Workspace Technologies, Inc., Carbon Source, Inc., CoroWare Treasury, Inc., and CarbonMeta Research Ltd., and its two majority owned subsidiaries CarbonMeta Green Building Materials, LLC and ARiCon, LLC (collectively, the “Company”). All significant inter-company balances and transactions have been eliminated in the consolidated financial statements.

 

Use of Estimates

 

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The Company uses all available information and appropriate techniques to develop its estimates. However, actual results could differ from its estimates.

 

Foreign Currency Translation

 

The accompanying consolidated financial statements are presented in United States dollars (“$”), which is the reporting currency of the Company. The functional currency of CarbonMeta Research Ltd. (“CMR”) is the Great Britain pound (“GBP”); the functional currency of the Company and its other subsidiaries is the United States dollar. The assets and liabilities of CMR are translated at the GBR currency exchange rate at the end of the period ($1.236823 at March 31, 2023), the revenues and expenses of CMR are translated at the GBP average exchange rates during the period ($1.223491 for the three months ended March 31, 2023), and stockholders’ equity (deficit) of CMR is translated at the historical exchange rates. The resulting translation adjustments are included in determining other comprehensive income (loss). Transaction gains and losses, which were not significant for the periods presented, are reflected in the consolidated statements of operations.

 

Cash and Cash Equivalents

 

The Company considers highly liquid investments with original maturities of three months or less when purchased as cash equivalents. The Company had no cash equivalents as of March 31, 2023 and December 31, 2022. At times throughout the year, the Company might maintain bank balances that may exceed Federal Deposit Insurance Corporation (“FDIC”) insured limits. Periodically, the Company evaluates the credit worthiness of the financial institutions and has not experienced any losses in such accounts. As of March 31, 2023 and December 31, 2022, the Company did not have bank balances that exceeded the FDIC insured limits.

 

Property and Equipment

 

Property and equipment are recorded at cost. Expenditures for major renewals and improvements are capitalized while expenditures for minor replacements, maintenance and repairs are expensed as incurred. Depreciation is calculated using the straight-line method over the estimated useful lives of the assets. Upon retirement or disposal of assets, the accounts are relieved of cost and accumulated depreciation and the related gain or loss, if any, is reflected in loss on disposal of assets in the consolidated statement of income and comprehensive income.

 

At least annually, the Company evaluates, and adjusts when necessary, the estimated useful lives. There were no changes in estimated useful lives for the periods presented. The estimated useful lives are: 

 

Computer equipment and software   5 years 
Filament production equipment   3 years 

 

Licenses

 

The licenses acquired from Oxford University Innovation Limited and Ecomena Limited (see Note A) are stated at cost less accumulated amortization. For the Oxford license, amortization is calculated using the straight-line method over the 10-year estimated life of the license. For the Ecomena license, amortization is calculated using the straight-line method over the 5-year term of the license.

 

13
 

 

CARBONMETA TECHNOLOGIES, INC.

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

For the three months ended March 31, 2023 and 2022

(Unaudited)

 

NOTE B – SIGNIFICANT ACCOUNTING POLICIES (continued)

 

Impairment of Long-lived Assets

 

The Company evaluates the carrying value and recoverability of its long-lived assets when circumstances warrant such evaluation by applying the provisions of Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 360-35, Property, Plant and Equipment, Subsequent Measurement (“ASC 360-35”). ASC 360-35 requires that long-lived assets be reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable through the estimated undiscounted cash flows expected to result from the use and eventual disposition of the assets. Whenever any such impairment exists, an impairment loss will be recognized for the amount by which the carrying value exceeds the fair value.

 

Income Taxes

 

Income taxes are computed using the asset and liability method. Under the asset and liability method, deferred income tax assets and liabilities are determined based on the differences between the financial reporting and tax bases of assets and liabilities and are measured using the currently enacted tax rates and laws. A valuation allowance is provided for the amount of deferred tax assets that, based on available evidence, are not expected to be realized. Additionally, taxes are calculated and expensed in accordance with applicable tax code.

 

Segment Reporting

 

FASB ASC 280-10, Segment Reporting, defines operating segments as components of a company about which separate financial information is available that is evaluated regularly by the chief decision maker in deciding how to allocate resources and in assessing performance. The Company reports according to one main segment.

 

Fair Value of Financial Instruments

 

The Company follows FASB ASC 820-10-35-37 (“Paragraph 820-10-35-37”) to measure the fair value of its financial instruments and paragraph 825-10-50-10 of the FASB ASC for disclosures about fair value of its financial instruments. Paragraph 820-10-35-37 establishes a framework for measuring fair value in GAAP and expands disclosures about fair value measurements. To increase consistency and comparability in fair value measurements and related disclosures, Paragraph 820-10-35-37 establishes a fair value hierarchy which prioritizes the inputs to valuation techniques used to measure fair value into three broad levels. The three levels of fair value hierarchy defined by Paragraph 820-10-35-37 are described below:

 

Level 1 Quoted market prices available in active markets for identical assets or liabilities as of the reporting date.
   
Level 2 Pricing inputs other than quoted prices in active markets included in Level 1, which are either directly or indirectly observable as of the reporting date.
   
Level 3 Pricing inputs that are generally unobservable inputs and not corroborated by market data.

 

Financial assets are considered Level 3 when their fair values are determined using pricing models, discounted cash flow methodologies or similar techniques and at least one significant model assumption or input is unobservable.

 

The fair value hierarchy gives the highest priority to quoted prices (unadjusted) in active markets for identical assets or liabilities and the lowest priority to unobservable inputs. If the inputs used to measure the financial assets and liabilities fall within more than one level described above, the categorization is based on the lowest level input that is significant to the fair value measurement of the instrument.

 

The carrying amounts reported in the Company’s consolidated financial statements for cash, accounts receivable and accounts payable and accrued expenses approximate their fair value because of the immediate or short-term nature of these financial instruments. The carrying amounts reported in the balance sheet for its notes and loans payable approximates fair value as the contractual interest rate and features are consistent with similar instruments of similar risk in the marketplace.

 

14
 

 

CARBONMETA TECHNOLOGIES, INC.

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

For the three months ended March 31, 2023 and 2022

(Unaudited)

 

NOTE B – SIGNIFICANT ACCOUNTING POLICIES (continued)

 

Transactions involving related parties cannot be presumed to be carried out on an arm’s-length basis, as the requisite conditions of competitive, free-market dealings may not exist. Representations about transactions with related parties, if made, shall not imply that the related party transactions were consummated on terms equivalent to those that prevail in arm’s-length transactions unless such representations can be substantiated.

 

It is not, however, practical to determine the fair value of advances from stockholders, if any, due to their related party nature.

 

The following table presents assets and liabilities that are measured and recognized at fair value as of March 31, 2023 and December 31, 2022, on a recurring basis:

 

SUMMARY OF ASSETS AND LIABILITIES MEASURED AND RECOGNIZED AT FAIR VALUE:

 

Assets and liabilities measured at fair value on a recurring basis at March 31, 2023  Level 1   Level 2   Level 3   Total Carrying Value 
                               
Derivative liabilities  $-   $(18,009,660)  $-   $(18,009,660)

 

Assets and liabilities measured at fair value on a recurring basis at December 31, 2022  Level 1   Level 2   Level 3   Total Carrying
Value
 
                              
Derivative liabilities  $-   $(9,652,846)  $-   $(9,652,846)

 

Convertible Instruments

 

The Company evaluates and accounts for conversion options embedded in its convertible instruments in accordance with professional standards for FASB ASC 815, Derivatives and Hedging (“ASC 815”).

 

Professional standards generally provide three criteria that, if met, require companies to bifurcate conversion options from their host instruments and account for them as free-standing derivative financial instruments. These three criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re-measured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument. Professional standards also provide an exception to this rule when the host instrument is deemed to be conventional as defined under professional standards as “The Meaning of Conventional Convertible Debt Instrument.”

 

The Company accounts for convertible instruments (when it has determined that the embedded conversion options should not be bifurcated from their host instruments) in accordance with professional standards under “Accounting for Convertible Securities with Beneficial Conversion Features,” as those professional standards pertain to “Certain Convertible Instruments.” Accordingly, the Company records, when necessary, discounts to convertible notes for the intrinsic value of conversion options embedded in debt instruments based upon the differences between the fair value of the underlying common stock at the commitment date of the note transaction and the effective conversion price embedded in the note. Debt discounts under these arrangements are amortized over the term of the related debt to their earliest date of redemption. The Company also records when necessary deemed dividends for the intrinsic value of conversion options embedded in preferred shares based upon the differences between the fair value of the underlying common stock at the commitment date of the preferred stock transaction and the effective conversion price embedded in the preferred stock. ASC 815 provides that, among other things, generally, if an event is not within the entity’s control, could or require net cash settlement, then the contract shall be classified as an asset or a liability.

 

15
 

 

CARBONMETA TECHNOLOGIES, INC.

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

For the three months ended March 31, 2023 and 2022

(Unaudited)

 

NOTE B – SIGNIFICANT ACCOUNTING POLICIES (continued)

 

Stock Based Compensation

 

The Company follows FASB ASC 718, Compensation – Stock Compensation, which prescribes accounting and reporting standards for all share-based payment transactions in which employee services are acquired. Transactions include incurring liabilities, or issuing or offering to issue shares, options, and other equity instruments such as employee stock ownership plans and stock appreciation rights. Share-based payments to employees, including grants of employee stock options, are recognized as compensation expense in the consolidated financial statements based on their fair values. That expense is recognized over the period during which an employee is required to provide services in exchange for the award, known as the requisite service period (usually the vesting period).

 

The Company accounts for stock-based compensation issued to non-employees and consultants in accordance with the provisions of FASB ASC 505-50, Equity–based Payments to Non-Employees. Measurement of share-based payment transactions with non-employees is based on the fair value of whichever is more reliably measurable: (a) the goods or services received; or (b) the equity instruments issued. The fair value of the share-based payment transaction is determined at the earlier of performance commitment date or performance completion date.

 

Through newly issued restricted common stock, the Company pays qualified contractors and advisors common shares in lieu of compensation for services provided including business development, management, technology development, consulting, legal services and accounting services.

 

Revenue Recognition

 

The Company will recognize revenue for its sales of energy products pursuant to the License Agreements with Oxford University Innovation Limited and Ecomena Limited (see Note A) when persuasive evidence of an arrangement exists, delivery has occurred, the sales price is fixed or determinable and collectability is probable. Product sales will be recognized by us generally at the time product is shipped. Shipping and handling costs will be included in cost of goods sold.

 

Research and Development

 

Research and development costs relate to the development of new products, including significant improvements and refinements to existing products, and are expensed as incurred. Research and development expenses for the three months ended March 31, 2023 and 2022 were $9,330 and $4,099, respectively.

 

Basic and Diluted Loss per Common Share

 

The Company computes basic and diluted earnings per common share amounts in accordance with FASB ASC 260, Earnings per Share. Basic earnings per common share is computed by dividing net income (loss) available to common shareholders by the weighted average number of common shares outstanding during the reporting period. Diluted earnings per common share reflects the potential dilution that could occur if stock options, convertible securities and other commitments to issue common stock were exercised or equity awards vest resulting in the issuance of common stock that could share in the earnings of the Company.

 

The Company currently has convertible debt and preferred stock, which, if converted, as of March 31, 2023 and 2022, would have caused the Company to issue diluted shares totaling 39,570,016,202 and 36,345,298,945, respectively.

 

Dividend Policy

 

The Company has never declared or paid any cash dividends on its common stock. The Company anticipates that any earnings will be retained for development and expansion of its business and does not anticipate paying any cash dividends in the foreseeable future. Additionally, as of March 31, 2023 and December 31, 2022, the Company has issued, and has outstanding, shares of Series B Preferred Stock which are entitled, prior to the declaration of any dividends on common stock, to earn a 5% dividend, payable in either cash or common stock of the Company. The Board of Directors has sole discretion to declare dividends based on the Company’s financial condition, results of operations, capital requirements, contractual obligations and other relevant factors. At March 31, 2023 and December 31, 2022, there were cumulative undeclared dividends to Preferred Series B shareholders of $129,724 and $127,728, respectively, the obligation for which is contingent on declaration by the board of directors. At March 31, 2023 and December 31, 2022 there were accrued unpaid declared dividends of $15,969 and $15,969, respectively (which are included in accounts payable and accrued expenses).

 

Recent Accounting Pronouncements

 

Certain accounting pronouncements have been issued by the FASB and other standard setting organizations which are not yet effective and therefore have not yet been adopted by the Company. The impact on the Company’s financial position and results of operations from adoption of these standards is not expected to be material.

 

16
 

 

CARBONMETA TECHNOLOGIES, INC.

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

For the three months ended March 31, 2023 and 2022

(Unaudited)

 

NOTE C – GOING CONCERN

 

The Company has a working capital deficit of $33,484,351 and $24,786,737 as of March 31, 2023 and December 31, 2022, respectively. The Company has accumulated deficits of $72,811,862 and $64,003,956 as of March 31, 2023 and December 31, 2022, respectively. Additionally, the Company is in default of substantially all of its debt and other obligations (see Notes F, H, I and K). Because of these and other factors, the Company will require additional working capital to develop its business operations. The Company intends to raise additional working capital through the use of private placements, public offerings and/or bank financing.

 

There are no assurances that the Company will be able to either (1) achieve a level of revenues adequate to generate sufficient cash flow from operations; or (2) obtain additional financing through either private placements, public offerings and/or bank financing necessary to support the Company’s working capital requirements. To the extent that funds generated from operations, any private placements, public offerings and/or bank financing are insufficient, the Company will have to raise additional working capital. No assurance can be given that additional financing will be available, or if available, will be on terms acceptable to the Company.

 

These conditions raise substantial doubt about the Company’s ability to continue as a going concern. The consolidated financial statements do not include any adjustments relating to the recoverability and classification of asset carrying amounts or the amount and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.

 

NOTE D – PROPERTY AND EQUIPMENT, NET

 

Property and equipment, net, consists of the following at March 31, 2023 and December 31, 2022:

 

   March 31,   December 31, 
   2023   2022 
Computer equipment and software  $1,325   $1,325 
Filament production equipment   45,799    45,799 
Subtotal   47,124    47,124 
Less: accumulated depreciation   (22,065)   (18,235)
Property and equipment, net  $25,059   $28,889 

 

Depreciation of equipment expense for the three months ended March 31, 2023 and 2022 was $3,830 and $3,830, respectively.

 

NOTE E – LICENSES, NET

 

The licenses, net, consist of the following at March 31, 2023 and December 31, 2022:

 

   March 31,   December 31, 
   2023   2022 
License acquired from Oxford University Innovation Limited on June 2, 2021 (see Note A)  $79,256   $79,256 
License acquired from Ecomena Limited effective February 17, 2022 (see Note A)   91,247    91,247 
Subtotal   170,503    

170,503

 
Accumulated amortization   (38,683)   (32,229)
License, net  $131,820   $138,274 

 

Amortization of licenses expense for the three months ended March 31, 2023 and 2022 was $6,454 and $7,904, respectively.

 

At March 31, 2023, the expected future amortization of licenses expense was:

 

Fiscal year ending December 31:    
2023 (excluding the three months ended March 31, 2023)  $19,721 
2024